PeptX supplies Cagrilintide, the long-acting amylin receptor agonist developed by Novo Nordisk and widely studied as part of the CagriSema research programme, to UK research laboratories and group-buy collectives. manufacturer-stated 99%+ purity, tracked UK delivery, GBP pricing.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.